NCT02159989
- Conditions
- Adenoma, Adenoma, Islet Cell, Adnexal Diseases, +33 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Pancreatic Neuroendocrine Tumor
Explore clinical trials studying Pancreatic Neuroendocrine Tumor. Study availability and eligibility vary by location and protocol.
36 public trials
10 recruiting studies
Pancreatic Neuroendocrine Tumor trial results
NCT06024343
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +12 more
- Locations
-
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06557408
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +12 more
- Locations
-
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center Shanghai, Shanghai, China Shanghai, Shanghai Municipality, China
Completed
Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
NCT00970970
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Adenoma, +45 more
- Locations
-
- University Medical Center Groningen Groningen, Netherlands
NCT05476978
- Conditions
- Adenoma, Adenoma, Islet Cell, Autoimmune Diseases, +20 more
- Locations
-
- Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT01466036
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05171517
- Conditions
- Adenoma, Adenoma, Islet Cell, Autoimmune Diseases, +21 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
NCT05800106
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
- Locations
-
- Affiliated Hospital of Changchun University of Traditional Chinese Medicine Changchun, Jilin, China
NCT03147768
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +33 more
- Locations
-
- Baylor CHI St. Luke's Medical Center Houston, Texas, United States
Completed
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
NCT02355535
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +17 more
- Locations
-
- University of Illinois at Chicago Chicago, Illinois, United States
- Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
- Regions Hospital Saint Paul, Minnesota, United States